# Kiora Pharmaceuticals Inc: Form 8-K, filed Dec 20, 2018

- Company: [Kiora Pharmaceuticals Inc](/companies/kprx.md) (CIK 1372514)
- Form: 8-K
- Filed: 2018-12-20
- Accepted by EDGAR: Dec 20, 2018, 16:30 ET
- Period: 2018-12-14
- Accession: 0001144204-18-065743
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1372514/000114420418065743/tv509612_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1372514/000114420418065743/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1372514/000114420418065743/tv509612_8k.htm

Filed Dec 20, 2018.
Source: SEC EDGAR, the filing index for accession 0001144204-18-065743. Last ingested by Listed: Nov 12, 2026, 17:43 ET. No prices; not investment advice.
